Opportunity
DIBBS #SPE2DP-26-T-2644
DLA Solicitation for Meloxicam Tablets, 15 mg, 100-count Bottles
Posted
April 06, 2026
Respond By
April 13, 2026
Identifier
SPE2DP-26-T-2644
NAICS
325412
This procurement opportunity from the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA seeks Meloxicam Tablets for military use. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA, Philadelphia, PA - OEMs (Original Equipment Manufacturers): - Zydus Pharmaceuticals (USA) Inc. (NDC68382-0051-01) - XLCARE Pharmaceuticals Inc. (NDC72865-0138-01) - Exelan Pharmaceuticals Inc. (NDC76282-0153-01) - Vendors: Same as OEMs (no resellers specified) - Products Requested: - Meloxicam Tablets, 15 mg, 100-count bottles (NSN 6505-01-541-3243) - Total quantity: 5 bottles (each bottle contains 100 tablets) - Packaging and marking must comply with Medical Marking Standard No. 1 - Delivery & Performance: - Delivery required FOB destination within 20 days of contract award - Delivery location: USS Lewis B Puller ESB 3 (Unit 100195 Box 1, FPO AE 09591) - Notable Requirements: - Only approved manufacturers (Zydus, XLCARE, Exelan) are acceptable - Compliance with DFARS/FAR clauses, including cybersecurity and hazardous material handling - Fast award process indicated
Description
MELOXICAM TABLETS (QTY: 5, NSN: 6505-01-541-3243, Purchase Request: 7016187061) Approved Sources: - CAGE: 6GFC4, Part No: NDC76282-0153-01, Company: EXELAN PHARMACEUTICALS INC - CAGE: 6YA44, Part No: NDC68382-0051-01, Company: ZYDUS PHARMACEUTICALS (USA) INC. - CAGE: 86SL9, Part No: NDC72865-0138-01, Company: XLCARE PHARMACEUTICALS INC